drugset / Trial / NCT00684957
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
RandomizedCrossoverOpen-labelDiagnostic
Summary
The purpose of this study is to see if giving growth hormone or insulin-like growth factor-1 (IGF-1) to subjects with growth hormone deficiency effects cardiovascular risk factors differently.
Timeline
- Start
- 2008-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Somatropin | Protein / enzyme biologic | 400 ug | Subcutaneous |
| Comparator | mecasermin | Protein / enzyme biologic | 30 ug/kg | — |